Skip to main content
. Author manuscript; available in PMC: 2011 Oct 30.
Published in final edited form as: Psychiatry Res. 2010 Sep 15;184(1):49–56. doi: 10.1016/j.pscychresns.2010.07.006

Table 2.

MRI and DTI metrics (raw data) in the three groups

Control Alzheimer Alcoholic
MRI corpus callosum height (mm) 26 ± 3 29 ± 5 26 ± 4
corpus callosum length (mm) 74 ± 4 76 ± 7 73 ± 5
Total corpus callosum area (mm2) 406 ± 43 364 ± 38 370 ± 28
Genu area (mm2) 84 ± 14 68 ± 13 69 ± 9
Body area (mm2) 194 ± 27 186 ± 36 177 ± 22
Splenium area (mm2) 129 ± 16 110 ± 10 124 ± 17
Lateral ventricles volume (cm3) 25 ± 9 60 ± 27 35 ± 18
DTI Total corpus callosum FA 0.48 ± 0.03 0.41 ± 0.04 0.44 ± 0.04
MD 0.60 ± 0.05 0.70 ± 0.06 0.66 ± 0.06
Genu FA 0.44 ± 0.05 0.36 ± 0.05 0.39 ± 0.04
FA: rarefied sample 0.64 ± 0.09 0.49 ± 0.07 0.53 ± 0.09
MD (10−3 mm2 /s) 0.60 ± 0.07 0.72 ± 0.09 0.66 ± 0.07
MD (10−3mm2 /s): rarefied sample 0.58 ± 0.09 0.77 ± 0.10 0.68 ± 0.09
Body FA 0.46 ± 0.04 0.38 ± 0.04 0.41 ± 0.04
MD (10−3 mm2/s) 0.62 ± 0.56 0.73 ± 0.07 0.70 ± 0.06
Splenium FA 0.55 ± 0.04 0.49 ± 0.05 0.51 ± 0.05
FA: rarefied sample 0.80 ± 0.07 0.80 ± 0.06 0.80 ± 0.07
MD (10−3mm2/ s) 0.56 ± 0.05 0.62 ± 0.06 0.59 ± 0.07
MD (10−3mm2 /s): rarefied sample 0.48 ± 0.05 0.49 ± 0.05 0.48 ± 0.06